Pfizer Reaches Three Settlement Agreements for VYNDAMAX
Pfizer has reached settlement agreements with multiple generic manufacturers over VYNDAMAX (tafamidis),…
Bayer’s Kerendia Gains EU Approval for Expanded Use in Heart Failure Treatment
Bayer receives European Commission approval to expand the use of Kerendia (finerenone)…
WHO Urges Countries to Raise Taxes on Sugary Drinks and Alcohol to Tackle Rising Global Health Risks
WHO is urging governments worldwide to raise taxes on sugary drinks and…
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more…
Why Are Heart Attacks Increasing Among Young Adults?
Cardiovascular disease remains the world’s leading cause of death, claiming millions of…
Uncontrolled high blood pressure puts over a billion people at risk
The World Health Organization (WHO) today released its second Global hypertension report, showing…
Charité and Siemens Healthineers jointly develop innovative concepts
Charité – Universitätsmedizin Berlin and Siemens Healthineers will work more closely together…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…
How cardiovascular disease affects women: myths, facts, and realities
Cardiovascular disease (CVD) is the leading cause of death for both men…
